← FDA Drug Approvals (Drugs@FDA)

OMEPRAZOLE AND SODIUM BICARBONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2016-12-06

Drug application

FDA Application #

ANDA207476

Application type

Abbreviated New Drug Application (Generic)

Brand name

OMEPRAZOLE AND SODIUM BICARBONATE

Generic name

OMEPRAZOLE SODIUM BICARBONATE

Active ingredients

OMEPRAZOLE; SODIUM BICARBONATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

Cipla USA Inc.

First approval

2016-12-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown